Indication
Replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old).
Loading your page…
Loading your page…
Adrenal Insufficiency
Marketing Authorisation Holder: Immedica Netherlands B.V.
EMA Authorisation: 09/02/2018
INN: hydrocortisone
AI Drug & Interaction Analysis
Free account required
Ask Osler about Alkindi: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.